LLY

754.62

+0.26%↑

JNJ

176.82

-0.47%↓

ABBV

216.68

+0.24%↑

UNH

341.39

-2.01%↓

AZN

77.65

-0.21%↓

LLY

754.62

+0.26%↑

JNJ

176.82

-0.47%↓

ABBV

216.68

+0.24%↑

UNH

341.39

-2.01%↓

AZN

77.65

-0.21%↓

LLY

754.62

+0.26%↑

JNJ

176.82

-0.47%↓

ABBV

216.68

+0.24%↑

UNH

341.39

-2.01%↓

AZN

77.65

-0.21%↓

LLY

754.62

+0.26%↑

JNJ

176.82

-0.47%↓

ABBV

216.68

+0.24%↑

UNH

341.39

-2.01%↓

AZN

77.65

-0.21%↓

LLY

754.62

+0.26%↑

JNJ

176.82

-0.47%↓

ABBV

216.68

+0.24%↑

UNH

341.39

-2.01%↓

AZN

77.65

-0.21%↓

Search

Innoviva Inc

Abrir

SetorSaúde

19.48 -0.87

Visão Geral

Variação de preço das ações

24h

Atual

Mín

19.3

Máximo

19.69

Indicadores-chave

By Trading Economics

Rendimento

110M

64M

Vendas

12M

100M

P/E

Médio do Setor

35.895

35.664

Margem de lucro

63.508

Funcionários

127

EBITDA

111M

84M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+107.8% upside

Dividendos

By Dow Jones

Próximos Ganhos

4 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

124M

1.3B

Abertura anterior

20.35

Fecho anterior

19.48

Sentimento de Notícias

By Acuity

12%

88%

11 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Innoviva Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de set. de 2025, 22:39 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 de set. de 2025, 16:43 UTC

Grandes Movimentos do Mercado

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 de set. de 2025, 16:42 UTC

Grandes Movimentos do Mercado

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 de set. de 2025, 16:35 UTC

Grandes Movimentos do Mercado

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 de set. de 2025, 23:46 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 de set. de 2025, 23:46 UTC

Conversa de Mercado

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 de set. de 2025, 23:34 UTC

Conversa de Mercado

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 de set. de 2025, 22:48 UTC

Conversa de Mercado

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 de set. de 2025, 22:12 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Expects Commercial Launch in 2029

15 de set. de 2025, 22:12 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 de set. de 2025, 22:11 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 de set. de 2025, 22:11 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 de set. de 2025, 22:10 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 de set. de 2025, 21:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 de set. de 2025, 21:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 de set. de 2025, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 de set. de 2025, 21:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 de set. de 2025, 20:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

15 de set. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

15 de set. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

15 de set. de 2025, 19:29 UTC

Conversa de Mercado

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 de set. de 2025, 19:14 UTC

Conversa de Mercado

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 de set. de 2025, 18:16 UTC

Conversa de Mercado

Gold Powers to New High -- Market Talk

15 de set. de 2025, 18:05 UTC

Conversa de Mercado

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 de set. de 2025, 17:50 UTC

Aquisições, Fusões, Aquisições de Empresas

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 de set. de 2025, 17:10 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 de set. de 2025, 17:10 UTC

Conversa de Mercado

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 de set. de 2025, 16:52 UTC

Conversa de Mercado

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 de set. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

15 de set. de 2025, 16:20 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

Comparação entre Pares

Variação de preço

Innoviva Inc Previsão

Preço-alvo

By TipRanks

107.8% parte superior

Previsão para 12 meses

Média 40.25 USD  107.8%

Máximo 55 USD

Mínimo 26 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Innoviva Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

4

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

18.57 / 18.75Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bullish Evidence

Longo Prazo

Neutral Evidence

Sentimento

By Acuity

11 / 371 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Innoviva Inc

Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; GIAPREZA (angiotensin II), a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock; XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections in adults; and XACDURO, a beta lactamase inhibitor for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Its development pipeline includes zoliflodacin, a late-stage product candidate, a potential single oral dose cure for the treatment of uncomplicated gonorrhea. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
help-icon Live chat